Cargando…
Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy
Leishmaniasis is a parasitic disease of humans, highly prevalent in parts of the tropics, subtropics, and southern Europe. The disease mainly occurs in three different clinical forms namely cutaneous, mucocutaneous, and visceral leishmaniasis (VL). The VL affects several internal organs and is the d...
Autores principales: | Dayakar, Alti, Chandrasekaran, Sambamurthy, Kuchipudi, Suresh V., Kalangi, Suresh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459942/ https://www.ncbi.nlm.nih.gov/pubmed/31024534 http://dx.doi.org/10.3389/fimmu.2019.00670 |
Ejemplares similares
-
Emergence of Leptin in Infection and Immunity: Scope and Challenges in Vaccines Formulation
por: Alti, Dayakar, et al.
Publicado: (2018) -
Leptin regulates Granzyme-A, PD-1 and CTLA-4 expression in T cell to control visceral leishmaniasis in BALB/c Mice
por: Dayakar, Alti, et al.
Publicado: (2017) -
Gold–Silver Bimetallic Nanoparticles Reduced
with Herbal Leaf Extracts Induce ROS-Mediated Death in Both Promastigote
and Amastigote Stages of Leishmania donovani
por: Alti, Dayakar, et al.
Publicado: (2020) -
Immunotherapy and Immunochemotherapy in Visceral Leishmaniasis: Promising Treatments for this Neglected Disease
por: Roatt, Bruno Mendes, et al.
Publicado: (2014) -
Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)